Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ORCC
|
Regents Of The University Of California |
SELL
Open market or private sale
|
Direct | 43,593 Reduced 0.1% |
$554,939
$12.73 p/Share
|
Jul 15
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 172 Added 0.06% |
$102,638
$596.73 p/Share
|
Jul 15
2020 |
|
BGNE
|
Amgen Inc
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct | 29,614,832 Added 11.14% |
$421,419,046
$14.23 p/Share
|
Jul 15
2020 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.27% |
$4,337,900
$433.79 p/Share
|
Jul 15
2020 |
|
ADBE
|
Scott Belsky
Chief Strategy Officer & EVP |
SELL
Open market or private sale
|
Direct | 600 Reduced 4.88% |
$261,096
$435.16 p/Share
|
Jul 15
2020 |
|
ARLO
|
Grady Summers |
BUY
Open market or private purchase
|
Direct | 483 Added 0.37% |
$1,425
$2.95 p/Share
|
Jul 15
2020 |
|
CFB
|
David L. O'Toole
CHIEF INVESTMENT OFFICER |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.34% |
$4,910
$9.82 p/Share
|
Jul 15
2020 |
|
PFXNZ
|
Fortress Investment Group LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 52,800 Reduced 0.82% |
$33,264
$0.63 p/Share
|
Jul 15
2020 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 68,670 Reduced 0.06% |
$20,932,675
$304.83 p/Share
|
Jul 15
2020 |
|
CFB
|
Mike Maddox
PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 5.42% |
$101,100
$10.11 p/Share
|
Jul 15
2020 |
|
CFB
|
Mike Maddox
PRESIDENT AND CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 4,946 Reduced 2.86% |
$50,004
$10.11 p/Share
|
Jul 15
2020 |
|
CFB
|
Mike Maddox
PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,484 Reduced 0.85% |
$15,003
$10.11 p/Share
|
Jul 15
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$2,840,550
$189.37 p/Share
|
Jul 15
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Jul 15
2020 |
|
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,500 Added 0.03% |
$5,145
$1.47 p/Share
|
Jul 15
2020 |
|
ARES
|
R. Kipp De Veer
Co-President |
SELL
Open market or private sale
|
Direct | 34,464 Reduced 3.03% |
$1,388,555
$40.29 p/Share
|
Jul 15
2020 |
|
VTR
|
Matthew J Lustig
Director |
BUY
Grant, award, or other acquisition
|
Direct | 248 Added 0.52% |
$8,722
$35.17 p/Share
|
Jul 14
2020 |
|
VTR
|
Jay M Gellert
Director |
BUY
Grant, award, or other acquisition
|
Direct | 625 Added 0.37% |
$21,981
$35.17 p/Share
|
Jul 14
2020 |
|
VTR
|
James D Shelton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 198 Added 0.37% |
$6,963
$35.17 p/Share
|
Jul 14
2020 |
|
VTR
|
Roxanne M Martino
Director |
BUY
Grant, award, or other acquisition
|
Direct | 135 Added 0.51% |
$4,747
$35.17 p/Share
|
Jul 14
2020 |
|
REGN
|
Andrew J Murphy
EVP Research |
SELL
Open market or private sale
|
Direct | 3,929 Reduced 8.14% |
$2,441,873
$621.5 p/Share
|
Jul 14
2020 |
|
REGN
|
Andrew J Murphy
EVP Research |
SELL
Open market or private sale
|
Direct | 2,380 Reduced 5.37% |
$1,510,728
$634.76 p/Share
|
Jul 14
2020 |
|
REGN
|
Robert E Landry
EVP Finance CFO |
SELL
Open market or private sale
|
Direct | 579 Reduced 2.36% |
$370,849
$640.5 p/Share
|
Jul 14
2020 |
|
KRP
|
Robert Davis Ravnaas
President and CFO |
BUY
Other acquisition or disposition
|
Indirect | 1,384 Added 3.81% |
-
|
Jul 14
2020 |
|
KRP
|
Robert D. Ravnaas
Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect | 2,768 Added 3.81% |
-
|
Jul 14
2020 |
|
KRP
|
T Scott Martin
Director |
BUY
Other acquisition or disposition
|
Indirect | 870 Added 6.29% |
-
|
Jul 14
2020 |
|
OFC
|
Steven D Kesler |
BUY
Open market or private purchase
|
Direct | 7 Added 0.02% |
$181
$25.91 p/Share
|
Jul 14
2020 |
|
SPT
|
Jason Kreuziger
Director |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.0% |
$7,620
$25.4 p/Share
|
Jul 14
2020 |
|
SPT
|
Jason Kreuziger
Director |
SELL
Open market or private sale
|
Indirect | 300 Reduced 0.0% |
$7,620
$25.4 p/Share
|
Jul 14
2020 |
|
SPT
|
Mbd Advisors, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.0% |
$7,620
$25.4 p/Share
|
Jul 14
2020 |
|
SPT
|
Mbd Advisors, L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 300 Reduced 0.0% |
$7,620
$25.4 p/Share
|
Jul 14
2020 |
|
SPT
|
Goldman Sachs Group Inc
Director |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.0% |
$7,620
$25.4 p/Share
|
Jul 14
2020 |
|
SPT
|
Goldman Sachs Group Inc
Director |
SELL
Open market or private sale
|
Indirect | 300 Reduced 0.0% |
$7,620
$25.4 p/Share
|
Jul 14
2020 |
|
JBSS
|
Jeffrey T Sanfilippo
Chief Executive Officer |
SELL
Bona fide gift
|
Indirect | 1,203 Reduced 12.03% |
-
|
Jul 14
2020 |
|
JBSS
|
John E Sanfilippo |
BUY
Bona fide gift
|
Indirect | 882 Added 50.0% |
-
|
Jul 14
2020 |
|
JBSS
|
John E Sanfilippo |
SELL
Bona fide gift
|
Indirect | 1,203 Reduced 12.03% |
-
|
Jul 14
2020 |
|
JBSS
|
James J Sanfilippo |
BUY
Bona fide gift
|
Indirect | 321 Added 50.0% |
-
|
Jul 14
2020 |
|
BCYC
|
Glaxosmithkline PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,597 Reduced 0.08% |
$30,774
$19.27 p/Share
|
Jul 14
2020 |
|
NKTX
|
Novo Holdings
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 555,555 Added 16.59% |
$9,999,990
$18.0 p/Share
|
Jul 14
2020 |
|
NKTX
|
Novo Holdings
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 2,238,310 Added 50.0% |
-
|
Jul 14
2020 |
|
NKTX
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect | 3,333,333 Added 37.29% |
$59,999,994
$18.0 p/Share
|
Jul 14
2020 |
|
NKTX
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect | 2,271,796 Added 50.0% |
-
|
Jul 14
2020 |
|
PFXNZ
|
Fortress Investment Group LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,495 Reduced 0.08% |
$3,517
$0.64 p/Share
|
Jul 14
2020 |
|
ID
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.01% |
$1,080
$10.8 p/Share
|
Jul 14
2020 |
|
RAPT
|
Kleiner Perkins Caufield & Byers Xv, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 300,000 Reduced 8.46% |
-
|
Jul 14
2020 |
|
NKTX
|
Glaxosmithkline PLC
Director |
BUY
Open market or private purchase
|
Indirect | 833,333 Added 20.92% |
$14,999,994
$18.0 p/Share
|
Jul 14
2020 |
|
NKTX
|
Glaxosmithkline PLC
Director |
BUY
Conversion of derivative security
|
Indirect | 2,317,399 Added 46.33% |
-
|
Jul 14
2020 |
|
NKE
|
Hilary K Krane
EVP, CAO & General Counsel |
SELL
Open market or private sale
|
Direct | 11,000 Reduced 5.68% |
$1,059,630
$96.33 p/Share
|
Jul 14
2020 |
|
NKE
|
Hilary K Krane
EVP, CAO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 11,000 Added 5.37% |
$348,480
$31.68 p/Share
|
Jul 14
2020 |
|
TMUS
|
Lawrence Guffey
Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 1,350 Added 4.2% |
$139,050
$103.0 p/Share
|
Jul 14
2020 |